Penetration of brodimoprim into human neutrophils and intracellular activity

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2392-2398

  Braga, Pier Carlo ^a,c   Dal Sasso, Monica ^a   Maci, Samanta ^a   Bondiolotti, Gianpietro ^a   Fonti, Elena ^b   Reggio, Stefano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c Department of Pharmacology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; ANTIBIOTIC AGENT; BRODIMOPRIM; POTASSIUM FLUORIDE; TRIMETHOPRIM;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG PENETRATION; HUMAN; HUMAN CELL; NEUTROPHIL; NONHUMAN; PH; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TEMPERATURE SENSITIVITY;

EID: 0029824187     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2392     Document Type: Article

References (63)

1. Allen, R. C., R. L. Stjerhnholm, and R. H. Steels. 1972. Evidence for the generation of an electronic excitation state in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem. Biophys. Res. Commun. 47:674-684.
2. Arbo, A., and J. I. Santos. 1990. The in vitro effects of clindamycin on polymorphonuclear leucocyte functions. A reassessment. Drug Invest. 2:235-241.
3. 4-acetyl metabolite in biological fluids by normal-phase high performance liquid chromatography. J. Chromatogr. 224:59-66.
4. Bøyum, A., D. Løvhaug, and L. Tresland. 1991. Density-dependent separation of white blood cells, p. 217-239. In J. R. Harris (ed.), Blood separation and plasma fraction. Wiley-Liss, Inc., New York.
5. Braga, P. C., M. Dal Sasso, S. Maci, L. Allegra, E. Fonti, A. Ghessi, and S. Reggio. 1995. Influence of brodimoprim on polymorphonuclear leukocyte phagocytosis and oxidant radical production. Chemotherapy (Basel) 41:360-367.
6. 5a. Braga, P. C., M. Dal Sasso, S. Maci, E. Fonti, G. P. Bondiolotti, and S. Reggio. 1995. Brodimoprim: uptake by human neutrophils and effects on neutrophil activities, abstr. A76, p. 15. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Braunsteiner, A. R., and F. Finsinger. 1993. Brodimoprim: therapeutic efficacy and safety in the treatment of bacterial infections. J. Chemother. 5:507-511.
8. Climax, J., T. J. Lenehan, R. Lambe, M. Kenny, E. Caffrey, and A. Darragh. 1986. Interaction of antimicrobial agents with human peripheral blood leucocytes: uptake and intracellular localization of certain sulphonamides and trimethoprim. J. Antimicrob. Chemother. 17:489-498.
9. Deysine, M., A. Chua, and A. Gerboth. 1979. Selective delivery of antibiotics to experimental infections by autologous white blood cells. Surg. Forum 30:38-39.
10. Dunker, D., and U. Ulmann. 1986. Influence of various antimicrobial agents on the chemiluminescence of phagocytosing human granulocytes. Chemotherapy (Basel) 32:18-24.
11. Easmon, C. S. F., and J. P. Crane. 1984. Cellular uptake of clindamycin and lincomycin. Br. J. Exp. Pathol. 65:725-730.
12. El Benna, J., C. Pasquier, and M. T. Labro. 1991. Quinine uptake by human polymorphonuclear neutrophils. Antimicrob. Agents Chemother. 35:1474-1478.
13. Fietta, A., P. Boeri, M. L. Colombo, C. Merlini, and G. Gialdroni Grassi. 1992. Uptake of flurithromycin by human polymorphonuclear phagocytes: partial characterization of the entry mechanism. Chemotherapy (Basel) 38: 433-440.
14. Ford, T. C., and J. M. Graham. 1991. An introduction to centrifugation. Bios Scientific Publisher, Oxford.
15. Gaspari, F., L. Taiocchi, and M. G. Pochobradsky. 1992. Determination of brodimoprim and its hydroxy metabolite in human plasma, blood, and urine by high-performance liquid chromatography. J. Chromatogr. 557:123-128.
16. Gladue, R. P., G. M. Bright, R. E. Isaacson, and M. F. Newborg. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob. Agents Chemother. 33:277-282.
17. 4-acetylsulphamethoxazole in serum and urine by high-performance liquid chromatography. J. Chromatogr. 233: 139-145.
18. Gründer, F. K., and R. A. Seger. 1981. Chronic granulomatous disease: mode of action of sulfamethoxazole/trimethoprim. Pediatr. Res. 15:1533-1537.
19. Hand, W. L., R. W. Corwin, T. H. Steinberg, and G. D. Grossman. 1984. Uptake of antibiotics by human alveolar macrophages. Am. Rev. Respir. Dis. 129:933-937.
20. Hand, W. L., and D. L. Hand. 1993. Interactions of dirithromycin with human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 37: 2557-2562.
21. Hand, W. L., D. L. Hand, and N. L. King-Thompson. 1990. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 34:863-870.
22. Hand, W. L., and N. L. King-Thompson. 1986. Contrast between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity. Antimicrob. Agents Chemother. 29:135-140.
23. Hand, W. L., and N. L. King-Thompson. 1990. Uptake of antibiotics by human polymorphonuclear leukocyte cytoplasts. Antimicrob. Agents Chemother. 34:1189-1193.
24. Hand, W. L., N. King-Thompson, and J. W. Holman. 1987 Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 31:1553-1557.
25. Hand, W. L., N. L. King-Thompson, and J. D. Johnson. 1984. Influence of bacterial-antibiotic interactions on subsequent antimicrobial activity of alveolar macrophages. J. Infect. Dis. 149:271-276.
26. Höger, P. H., R. A. Seger, U. B. Schaad, and W. H. Hitzig. 1985. Chronic granulomatous disease: uptake and intracellular activity of fosfomycin in granulocytes. Pediatr. Res. 19:38-44.
27. Ishiguro, M., H. Koga, S. Kohno, T. Hayashi, K. Yamaguchi, and M. Hirota. 1989. Penetration of macrolides into human polymorphonuclear leukocytes. J. Antimicrob. Chemother. 24:719-729.
28. Jacobs, R. F., and C. B. Wilson. 1983. Intracellular penetration and antimicrobial activity of antibiotics. J. Antimicrob. Chemother. 12(Suppl. C):13-20.
29. Jacobs, R. F., C. B. Wilson, J. G. Laxton, J. E. Haas, and A. L. Smith. 1982. Cellular uptake and intracellular activity of antibiotics against Haemophilus influenzae type b. J. Infect. Dis. 145:152-159.
30. Johnson, J. D., W. L. Hand, J. B. Francis, N. L. King-Thompson, and R. W. Corwin. 1980. Antibiotic uptake by alveolar macrophages. J. Lab. Clin. Med. 95:429-439.
31. Klempner, M. S., and B. Styrt. 1981. Clindamycin uptake by human neutrophils. J. Infect. Dis. 144:472-479.
32. Knowles, D. J. 1988. Uptake of erythromycin by McCoy and HEp2 cells: its dependence on cellular pH gradients. J. Antimicrob. Chemother. 21:765-772.
33. Koga, H. 1987. High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 31:1904-1908.
34. Kornguth, M. L., and C. M. Kunin. 1976. Uptake of antibiotics by human erythrocytes. J. Infect. Dis. 133:175-184.
35. Laufen, H., A. Wildfeuer, and K. Räder. 1985. Uptake of antimicrobial agents by human polymorphonuclear leukocytes. Arzneim.-Forsch. 35:1097-1099.
36. Lehrer, R. I., and M. J. Cline. 1969. Interaction of Candida albicans with human leukocytes and serum. J. Bacteriol. 98:996-1004.
37. Leijh, P. C. J., M. T. van den Barselaar, M. R. Daha, and R. van Furth. 1981. Participation of immunoglobulin and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect. Immun. 33:714-724.
38. Leijh, P. C. J., M. T. van den Barselaar, I. Dubbeldeman-Rempt, and R. van Furth. 1980. Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Eur. J. Immunol. 10:750-762.
39. Leijh, P. C. J., M. T. van den Barselaar, T. L. van Zwet, M. R. Daha, and R. van Furth. 1979. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J. Clin. Invest. 63:772-784.
40. Maderazo, E. G., C. J. Kripas, S. P. Breaux, C. L. Voronick, and R. Moore. 1989. Pitfalls in testing drug uptake by leukocytes using radiolabeled drugs and an explanation of conflicting results with clindamycin. Chemotherapy (Basel) 35:123-129.
41. Mandel, G. L. 1973. Interaction of intraleukocytic bacteria and antibiotics. J. Clin. Invest. 52:1673-1674.
42. McLeod, T. F., D. R. Manyan, and A. A. Yunis. 1977. The cellular transport of chloramphenicol and thiamphenicol. J. Lab. Clin. Med. 90:347-353.
43. 32P-labelled Escherichia coli by rat polymorphonuclear cells. Scand. J. Infect. Dis. 9:9-12.
44. 32P-labelled Escherichia coli by human polymorphonuclear cells. Acta Pathol. Microbiol. Scand. Sect. B 88:103-106.
45. Metcalf, J. A., J. I. Gallin, W. M. Nauseef, and R. K. Root. 1986. Laboratory manual of neutrophil function. Raven Press, New York.
46. Pascual, A., I. García, C. Conejo, and E. J. Perea. 1993. Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 37:187-190.
47. Patterson-Delfield, J., and R. I. Lehrer. 1977. A simple microscopic method for identifying and quantitating phagocytic cells in vitro. J. Immunol. Methods 18:377-379.
48. Peinado, J. M., K. T. McManus, and R. D. Myers. 1986. Rapid method for micro-analysis of endogenous amino acid neurotransmitters in brain perfusates in the rat by isocratic HLPL-EC. J. Neurosci. Methods 18:269-276.
49. Perry, D. K., W. L. Hand, D. E. Edmondson, and J. D. Lambeth. 1992. Role of phospholipase D-derived diradylglycerol in the activation of the human neutrophil respiratory burst oxidase-inhibition by phosphatidic acid phosphohydrolase inhibitors. J. Immunol. 149:2749-2758.
50. Prokesch, R. C., and W. L. Hand. 1982. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 21:373-380.
51. Raghoebar, M., J. A. M. Huisman, W. B. van den Berg, P. L. C. M. van Riel, and C. A. M. van Ginneken. 1988. Chloroquine interaction with inflammatory human polymorphonuclear leukocytes. Agents Actions 24:331-342.
52. Robinson, P., D. Wakefield, S. N. Breit, J. F. Easter, and R. Penny. 1984. Chemiluminescence response to pathogenic organisms: normal human polymorphonuclear leukocytes. Infect. Immun. 43:744-752.
53. Seger, R. A., S. Baumgartner, L. X. Tiefenauer, and F. K. Gründer. 1981. Chronic granulomatous disease: effect of sulfamethoxazole/trimethoprim on neutrophil microbicidal functions. Helv. Paediatr. Acta 36:579-588.
54. Siegel, J. P., and J. S. Remington. 1982. Effect of antimicrobial agents on chemiluminescence of human polymorphonuclear leukocytes in response to phagocytosis. J. Antimicrob. Chemother. 10:505-515.
55. 4-acetyl metabolite in biological fluids by high-performance liquid chromatography. J. Chromatogr. 274:187-199.
56. Steinberg, T. H., and W. L. Hand. 1984. Effects of phagocytosis of antibiotic and nucleoside uptake by human polymorphonuclear leukocytes. J. Infect. Dis. 149:397-403.
57. Stockis, A., F. Barzio, X. Deroubaix, F. Gasperi, B. Jeanbaptiste, E. Lebacq, R. Lins, D. Pavesio, G. C. Pelozi, and D. Rosillon. 1993. Pharmacokinetics of brodimoprim in special populations. J. Chemother. 5:480-487.
58. Then, R. L., E. Böhni, P. Angehrn, H. Plozza-Nottebrock, and K. Stoeckel. 1982. New analogs of trimethoprim. Rev. Infect. Dis. 4:372-377.
59. Vosbeck, K., P. R. James, and W. Zimmermann. 1983. Antibiotic action on phagocytosed bacteria measured by a new method for determining viable bacteria. Antimicrob. Agents Chemother. 25:735-741.
60. Weidekamm, E. 1993. Pharmacokinetics of brodimoprim. J. Chemother. 5:475-479.
61. Welch, W. D., D. Davis, and L. D. Thrupp. 1981. Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function. Antimicrob. Agents Chemother. 20:15-20.
62. Wilkinson, P. J., and D. S. Reeves. 1979. Tissue penetration of trimethoprim and sulphonamides. J. Antimicrob. Chemother. 5(Suppl. B):159-168.
63. Woods, P. B., and M. L. Robinson. 1981. An investigation of the comparative liposolubilities of β-adrenoceptor blocking agents. J. Pharm. Pharmacol. 33:172-173.